ArabFinance: The ordinary general meeting (OGM) of Kahira Pharmaceuticals and Chemical Industries Company (CPCI) approved the distribution of EGP 4 per share cash dividends to shareholders for fiscal year (FY) 2020/2021, according to a statement filed to the Egyptian Exchange (EGX).

It is worth noting that Kahira Pharmaceuticals reported a net profit after tax of EGP 124.30 million for fiscal year 2020/2021, compared to profits of EGP 109.14 million in FY 2019/2020.

Kahira Pharmaceuticals is an Egypt-based company involved in the manufacture and trade of pharmaceutical products for human and veterinary use.